This inventor holds 3 USPTO granted patents. Top assignees: University of Missouri, The University of North Carolina at Chapel Hill. Active years: 1997.
Company Filing History:
3 out of 894 
2 out of 1,325 
Years Active: 1997
Title: Claude E Parr: Innovator in Cell Growth Inhibition
Introduction
Claude E Parr is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell growth inhibition. With a total of 3 patents to his name, Parr's work has implications for medical research and therapeutic applications.
Latest Patents
Parr's latest patents include innovative methods related to the P.sub.2U receptor. One of his patents focuses on a method of inhibiting cell growth using the P.sub.2U receptor. This patent discloses isolated DNAs encoding the human P.sub.2U receptor, along with vectors and host cells that contain these elements. Additionally, it describes host cells that are essentially free of endogenous P.sub.2U receptor expression, which express a heterologous P.sub.2U receptor, such as a murine P.sub.2U receptor. The methods of using these host cells are also detailed in the patent.
Another significant patent by Parr involves methods of detecting compounds that bind to the P.sub.2U receptor. Similar to his previous patent, it discloses isolated DNAs encoding the human P.sub.2U receptor, vectors, and host cells. The methods of using these host cells are also outlined, showcasing the versatility and importance of his research.
Career Highlights
Throughout his career, Claude E Parr has worked with esteemed institutions such as the University of Missouri and the University of North Carolina at Chapel Hill. His work has contributed to advancements in understanding cell signaling and growth mechanisms, which are crucial for developing new therapeutic strategies.
Collaborations
Parr has collaborated with notable colleagues, including Richard C Boucher and Gary A Weisman. These collaborations have likely enriched his research and expanded the impact of his inventions.
Conclusion
Claude E Parr's innovative work in the field of biotechnology, particularly regarding the P.sub.2U receptor, has led to valuable patents that hold promise for future medical applications. His contributions continue to influence research in cell growth inhibition and detection methods.